TrialHaematologica2022

Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial

Cecilia Becattini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.